TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE

Coronavirus disease 2019 (COVID-19), caused by the late 2019 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a respiratory disease which could put myasthenia gravis (MG) patients at a greater risk of developing severe disease course, since infections and some drugs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Županić, Sven, Lazibat, Ines, Rubinić Majdak, Maja, Jeličić, Mia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907958/
https://www.ncbi.nlm.nih.gov/pubmed/35282492
http://dx.doi.org/10.20471/acc.2021.60.03.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907958/
https://www.ncbi.nlm.nih.gov/pubmed/35282492
http://dx.doi.org/10.20471/acc.2021.60.03.21

Ejemplares similares